Assessments used to calculate cardiovascular disease risk in the general population may not have the same predictive power ...
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
It might not be long until résumé are a thing of the past because most bosses are favoring skills-based hiring and reporting ...
What does a bad hire actually cost your organisation? For a mid-level manager earning Rs. 150,000 monthly, conservative ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
Living longer isn’t just about good genes or expensive treatments, it’s mostly about the small choices we make every day.
The probability of worsening frailty increases over time, but targeted strategies might delay or reverse this progression, ...
Cardiovascular imaging, which continues to evolve alongside interventions and other technologies, made notable strides in the ...
US intelligence agencies have concluded that Ukraine did not attempt to target Russian President Vladimir Putin, ...
MedPage Today on MSN
Gout and Its Comorbidities
The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, of Massachusetts General Hospital in Boston, at the American College of ...
FOLFIRINOX chemotherapy is feasible in selected elderly patients with pancreatic ductal adenocarcinoma, though toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback